Tablet Evaluation Tests/References
From Pharmpedia
References
| TOC :Tablet Evaluation Tests |
|
Introduction |
1. Rippie E. (1990) Compression of solids and compressed dosage forms. In: Encyclopedia of Pharmaceutical Technology. Swarbrick J. (Eds) Marcel Dekker Inc. NY. Vol. 3. pp. 149-166.
2. Rudnic E. and Schwartz J. B. Oral solid dosage forms In: Remington’s Pharmaceutical Sciences. 18th Ed. 1990. Ed. Gennaro, A. R. Mack Publishing Company. Easton, Pennsylvania, USA.pp. 1633-1665.
3. British Pharmacopoeia (1998) HMSO, London.
4. Seitz, J. A. and Flessland, G. M. (1965) Evaluation of physical properties of compressed tablets, 1: tablet hardness and friability. J. Pharm. Sci., 54: 1353-1357.
5. Upadrashta, S. M., Katikaneni, P. R. and Nuessla, N. O. (1992) Chitosan as a tablet binder. Drug Dev. Ind. Pharm., 18: 1701-1708.
6. Fell, J. T. and Newton, J. M. (1970) Determination of tablet strength by diametral - compression test. J. Pharm. Sci., 59: 688-691.
7. Odeku, O. A. and Itiola O. A. (2003) Evaluation of the effects of khaya gum on the mechanical and release properties of paracetamol tablet formulation. Drug Dev. Ind. Pharm., 29, 311-320.
8. Odeku, O. A. (2005) Assessment of Albizia zygia gum as binding agent in tablet formulations. Acta Pharm. 55:263-276.
9. Odeku, O. A and Itiola O. A. (1998) Evaluation of khaya gum as a binder in a paracetamol tablet formulation. Pharm. Pharmacol Commun, 4: 183-188.
10. Newton, J. M., Rowley, G., Fell, J. T., Peacock, D. G. and Ridgway, K. (1971) Computer analysis of the relation between tablet strength and compaction pressure. J. Pharm. Pharmacol., 23: 195S-201S.
11. Down, G. R. B. and McMullen, J. M. (1985) The effect of interparticulate friction and moisture on the crushing strength of sodium chloride compact. Powder Technol., 42: 169-174.
12. Hiestand, E. N. and Smith, D. P. (1984) Indices of tabletting performance. Powder Technol., 38: 145-159.
13. David, S. T. and Augsburger, L. L. (1977) Plastic flow during compression of directly compressible fillers and its effect on tablet strength. J. Pharm. Sci., 66: 155-159.
14. Jarosz, P. J. and Parrott, E. L. (1982) Factors influencing axial and radial tensile strengths of tablets J. Pharm. Sci., 71: 607 - 401.
15. Leuenberger, H. and Rohera, B. D. (1986) Fundamental properties of powder compression I. The compactibility and compressibility of pharmaceutical powders. Pharm. Res., 3: 12-22.
16. Celik, M. (1992) Overview of compaction data analysis techniques. Drug Dev. Ind. Pharm., 18: 767-810.
17. Hiestand, E. N., Wells, J. E., Poet, C. B. and Ochs, J. F. (1977) Physical processes of tabletting. J. Pharm. Sci. 66: 510 - 519.
18. Hiestand, E. N. Rationale for and the measurements of tableting indices. In: Pharmaceutical Powder Compaction Technology, Alderborn, G., Nystrom, C (Eds.) Marcel Dekker, New York, 1996, pp. 219-244.
19. Durelli, A. J. Lin, Y. H. (1986) Stress and displacements on boundaries of circular rings diametrically loaded. J. Appl. Mech. 53: 213-219.
20. Podzeck, F and Newton, J. M. (2003) The implications of the determination of the mechanical strength of powder compacts containing a pre-formed hole. Powder Technol. 132: 10-15.
21. Itiola, O. A. and Pilpel, N. (1986a) Tabletting characteristics of metronidazole formulations. Int. J. Pharm. 31: 99-105.
22. Roberts, R. J. and Rowe, R. C. (1986) The effect of the relationship between punch velocity and particle size on the compaction behaviour of materials with varying deformation mechanisms. J. Pharm. Pharmacol., 38: 566-571.
23. Itiola, O. A. (1991) Compressional characteristics of three starches and the mechanical properties of their tablets. Pharm. World J., 8(3) : 91-94.
24. Odeku, O. A. Awe, O. O. Popoola, B. Odeniyi, M. A. and Itiola, O. A. (2005) Compression and mechanical properties of tablet formulations containing corn, sweet potato, and cocoyam starches as binders. Pharm Tech 29 (4): 82-90.
25. Odeku, O. A. and Patani, B. O. (2005) Evaluation of dika nut mucilage (Irvingia gabonensis) as a binder in metronidazole tablet formulations. Pharm. Dev. Tech. 10: 439-446.
26. Banker, G. S. and Anderson, N. R., Tablets. In : The Theory and Practice of Industrial Pharmacy. Lachman, L., Lieberman, H. A. and Kanig, J. L. (Eds.) 3rd Edition. (1986) Lea & Febiger, Philadelphia, pp. 301-303.
27. Guyot-Hermann; (1992) The disintegration and disintegrating agent; S.T.P. Pharmaceutical Science: 2(6): 445-462.
28. Matsumaru, H. (1959) Mechanism of tablet compression and disintegration, IV. Evolution of wetting heat and its relation to compressional force. Yakugaku Zasshi, 79: 63-64.
29. Lowenthal, W. (1973) Mechanisms of action of tablet disintegrants. Pharm. Acta. Helv., 48: 589-609.
30. Ringard, J. and Guyot-Hermann, A. M. (1981) Disintegration mechanisms of tablets containing starches: Hypothesis about the particle-particle repulsive forces. Drug Dev. Ind. Pharm., 7: 155-177.
31. Kanig, J. L. and Rudnic, C. (1984) The mechanisms of disintegrant action. Pharm. Technol., 8: 50-62.
32. Shangraw, R., Mitrevej, A. and Shah, M. (1980) New era of tablet disintegrants. Powder Technol., 4: 49-57.
33. Singh, P., Desai, S. J., Simonelli, A. P. and Higuchi, W. I. (1968) Role of wetting on the rate of drug release from inert matrices. J. Pharm. Sci., 57: 217-226.
34. Ganderton, D. (1969) The effect of distribution of magnesium stearate on the penetration of a tablet by water J. Pharm. Pharmacol., 21(suppl.): 9S - 18S.
35. Kurup, T. R. R. and Pilpel, N. (1977) The tensile strength and disintegration of griseofulvin tablets. Powder Technol., 16: 843-847.
36. Ganderton, D. and Shotton, E. (1961) The strength of compressed tablet. III. The relation of particle size, bonding and capping of sodium chloride, aspirin and hexamine. J. Pharm. Pharmacol., 12: 144T-152T.
37. Nogami, H., Hagai, T., Fukuola, E. and Sonobe, T. (1969) Disintegration of aspirin tablets containing potato starch and microcrystalline cellulose in various concentrations. Chem. Pharm. Bull., 17(7) : 1450-1455.
38. Amidon, G.L., Lennernas, H. Shah, V.P. Crison, J.R. (1995) A Theoretical Basis for a Biopharmaceutical Drug Classification: The Correlation of In Vitro Drug Product Dissolution and In Vivo Bioavailability, Pharm Res, 12:413-420.
39. Levy, G (1961) Comparison of dissolution and absorption rates of different commercial aspirin tablets. J. Pharm. Sci., 50: 388-392.
40. Itiola, O. A. and Pilpel, N. (1986) Studies on metronidazole tablet formulations. J. Pharm. Pharmacol. 38: 81-86.
41. Itiola, O. A. and Pilpel, N. (1996) Effects of interacting variables on the disintegration and dissolution of metronidazole tablets. Pharmazie. 51: 997-998.
42. Odeku, O. A. and Itiola, O. A. (2003) Effects of interacting variables on the tensile strength and release properties of paracetamol tablet. Trop. J. Pharm. Res. 2 (1): 147-153.
43. Florence, A. T. and Halbert, G. W. (1990) Formulation. In: Comparative medicinal chemistry: The rational design, mechanistic study and therapeutic application of chemical compound. Hansch, C., Sammes, P. G. and Taylor, J. B. (Eds) Vol. 6. 1stEdition. Pergamon Press Plc. Oxford, UK. pp. 567-592.
44. Siewert, M., Dressman, J., Brown, C. K. and Shah, V. P. (2003) FIP/AAPS Guidelines to Dissolution/in vitro release testing of novel/special dosage forms. AAPS PharmSciTech 4 (1) Article 7 (http://www.pharmscitech.org).
45. Levy, G., Leonards, J. R. and Procknel, J. A. (1965) Development of in-vitro dissolution tests which correlate quantitatively with dissolution rate limited drug absorption in man. J. Pharm. Sci., 54: 1719-1722.
46. Levy, G. and Miller, K. E. (1964) Determination of drug absorption rates without chemical assay. J. Pharm. Sci., 53: 1301-1305.
47.Advances in dissolution test in pharmaceutical analysis Odeku, O. A. and Itiola, O. A. (2005)
48. Wurster, D. E. and Taylor, P. W. (1965) Dissolution rates. J. Pharm. Sci., 54: 169-175.
49. Swabrick, J. and Ma, D. (1981) In vitro dissolution of dapsone. J. Pharm. Pharmacol., 31: 787 - 789.
50. Higuchi, W. I. (1967) Diffusional models useful in biopharmaceutics drug release rate processes. J. Pharm. Sci., 56: 315-324.
51. Noyes, A. A. and Whitney, W. R. (1897) The rate of solution of solid substances in their own solutions. J. Am. Chem. Soc., 19: 930-934.
52. Aguiar, A. J., Krc, J., Kinkel, A. W. and Samyn, J. C. (1967) Effect of polymorphism on the absorption of chloramphenicol palmitate. J. Pharm. Sci., 56: 847-853.
53. Wagner, J. G. (1969) Interpretation of percent dissolved-time plots derived from in-vitro testing of conventional tablets and capsules. J. Pharm. Sci., 58: 1253-1257.
54. Kitazawa, S., Johno, I., Ito, Y., Teramura, S. and Okada, J. (1975) Effects of hardness on the disintegration time and the dissolution rate of uncoated caffeine tablets. J. Pharm. Pharmacol., 27: 765-770.
55. Kitazawa, S., Johno, I., Minouchi, T. and Okada, J. (1977) Interpretation of dissolution rate data from in-vitro testing of compressed tablets. J. Pharm. Pharmacol., 29: 453 - 459.
Retrieved from "http://www.pharmpedia.com/Tablet_Evaluation_Tests/References"
This page has been accessed 1,695 times. This page was last modified 21:22, 7 December 2005. All content, except where otherwise noted, is licensed under a Creative Commons Attribution License.
